Find the latest pharmaceutical market place for formulations enquiry about Atorvastatin on PharmaCompass.com.

Tender// Various Finished Dosage Formulations needed in Poland [ENA17088]

Zaglebie Centrum Onkologii Szpital Szpitalyczny im. Sz. Starkiewicza in Dabrowa Gornicza is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 9-Jun-23.
1. Amisulpride (200 mg) Tablets. The required quantity is 3,000 units.
2. Atorvastatin (20 mg) Tablets. The required quantity is 3,000 units.
3. Baclofen (10 mg) Tablets. The required quantity is 4,000 units.

Reply

13 May 2023

Tender// Various Finished Dosage Formulations needed in Romania [ENA16371]

Emergency Heart Institute For Cardiovascular Diseases "Niculae Stancioiu" Cluj-Napoca is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 13-Mar-2023.
1. Atorvastatin (40 mg) Tablets. The required quantity is 120,000 units.
2. Bisoprolol (5 mg) Tablets. The required quantity is 67,200 units.

Reply

14 Feb 2023

Tender// Various Finished Dosage Formulations needed in Belgium [ENA16167]

MercurHosp ASBL is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 31-Jan-2023.
1. Atorvastatin (20 mg) Tablets. The required quantity is 25,223 units.
2. Aripiprazole (15 mg) Tablets. The required quantity is 27,800 units.

Reply

21 Jan 2023

Atorvastatin (10 mg) Tablets needed in Armenia [ENA15980]

A company that deals in the distribution of various finished dosage formulations is looking for suppliers of Atorvastatin (10 mg) Tablets for commercial purposes. The required quantity is 500,000 units.

Reply

03 Jan 2023

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA15906]

Mnogoprofilna bolnitsa za aktivno lechenie "Natsionalna kardiologichna bolnitsa" EAD is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 20-Jan-2023.
1. Bisoprolol (2.5 mg) Tablets. The required quantity is 46,000 units.
2. Atorvastatin (40 mg) Tablets. The required quantity is 10,000 units.
3. Digoxin (0.25 mg) Tablets. The required quantity is 3,000 units.
4. Empagliflozin (10 mg) Tablets. The required quantity is 6,000 units.

Reply

24 Dec 2022

Various Finished Dosage Formulations needed in Yemen [ENA12492]

A company that deals in the distribution and marketing of pharmaceuticals and supplements is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with GMP. The required first order quantity is 5,000 units & total 25,000 units per annum for each.
1. Carbamazepine (200 mg) Tablets.
2. Atorvastatin (40 mg) Tablets.
3. Rosuvastatin (10 mg & 20 mg) Tablets.
4. Moxifloxacin (400 mg) Film-coated Tablets.

Reply

24 Jan 2022

Tender// Various Finished Dosage Formulations needed in Poland [ENA11756]

Szpital Powiatu Bytowskiego Sp. z o. o. is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 25-Nov-2021.
1. Folic Acid (15 mg) Tablets. The required quantity is 30 units.
2. Tranexamic Acid (500 mg) Tablets. The required quantity is 15 units.
3. Allopurinol (100 mg) Tablets. The required quantity is 20 units.
4. Atorvastatin (40 mg) Tablets. The required quantity is 40 units.
5. Citalopram (10 mg) Tablets. The required quantity is 30 units.

Reply

28 Oct 2021

saudiarabiapng-1555324364png-1605701218 Flag

Various Finished Dosage Formulations needed in United Arab Emirates [ENA11530]

A leading pharmaceutical company that deals in the manufacturing & distribution of generic pharmaceutical products in almost all lifestyle disease segments, including cardiovascular, anti-ulcerant, anti-diabetics, anti-arthritis, NSAIDs, respiratory, anti-histamine formulations, anti-infectives is looking for suppliers of Various Finished Dosage Formulations in bulk quantity. The suppliers must support this enquiry with EU-eCTD dossier with BE studies & CPP from a regulated market.
1. Sitagliptin Phosphate or Hydrochloride (50 mg) + Metformin HCl (500 mg, 850 mg &1000 mg) Tablets
2. Sitagliptin (50 mg) + Metformin Extended Release (500 mg & 1000 mg) Tablets
3. Sitagliptin Phosphate (50 mg & 100 mg) Tablets
4. Amlodipine Maleate (160 mg & 320 mg) + Valsartan (5 mg & 10 mg) Tablets
5. Amlodipine Maleate (160 mg) + Valsartan (5 mg & 10 mg) + Hydrochlorothiazide (12.5 mg & 25 mg) Tablets
6. Diclofenac (50 mg) Sachets
7. Aceclofenac (100 mg or 200 mg) Tablets
8. Aceclofenac (100 mg or 200 mg) Capsules
9. Nizatidine (150 mg or 300 mg) Tablets
10. Mosapride (5 mg & 15 mg) Tablets
11. Rosuvastatin (5 mg) + Omega 3 (1000 mg) Capsules
12. Atorvastatin (10 mg) + Omega 3 (1000 mg) Capsules
13. Cefdinir (300 mg) Capsules
14. Cefdinir (125 mg/ 5 ml) Oral Suspension

Reply

29 Sep 2021

United_States_of_America Flag

Various Finished Dosage Formulations needed in the United States [ENA11228]

A company that specializes in procuring and marketing pharmaceutical products, medical supplies, devices and equipment is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with EU certifications.
1. Acetylsalicylic Acid (325 mg) EC Tablets. The required quantity is 5,000 units.
2. Amlodipine (5 mg) Tablets. The required quantity is 10,000 units.
3. Anastrozole (1 mg) Tablets. The required quantity is 250 units.
4. Atorvastatin (10 mg & 20 mg) Tablets. The required quantity is 20,000 units & 10,000 units respectively.
5. Bevacizumab (100 mg & 400 mg) Injections. The required quantity is 40 units & 85 units respectively.
6. Bicalutamide (50 mg) Tablets. The required quantity is 200 units.
7. Carbimazole (20 mg & 5 mg) Tablets. The required quantity is 5,000 units each.
8. Carboplatin (150 mg) Injections. The required quantity is 50 units.
9. Carvedilol (12.5 mg & 25 mg) Tablets. The required quantity is 20,000 units each.
10. Cyclophosphamide (1000 mg) Injections. The required quantity is 100 units.

Reply

27 Aug 2021

Tender// Various Finished Dosage Formulations needed in Slovenia [ENA11019]

General Hospital Brezice is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 3-Sep-2021.
1. Acetylcysteine (600 mg) Effervescent Tablets. The required quantity is 1,080 units.
2. Allopurinol (100 mg) Tablets. The required quantity is 2,400 units.
3. Alprazolam (0.5 mg) Tablets. The required quantity is 5,400 units.
4. Aminophylline (250 mg / 10 ml) IV Solution for Injection. The required quantity is 1,200 units.
5. Amiodarone (150 mg / 3 ml) Solution for Injection. The required quantity is 1,000 units.
6. Amlodipine (5 mg) Tablets. The required quantity is 1,500 units.
7. Amoxicillin (875 mg) + Clavulanic Acid (125 mg) Film-Coated Tablets. The required quantity is 4,000 units.
8. Ascorbic Acid (1 g / 5 ml) Ampoules. The required quantity is 2,000 units.
9. Atorvastatin (20 mg) Film-Coated Tablets. The required quantity is 2,400 units.
10. Betahistine (8 mg) Tablets. The required quantity is 1,500 units.
11. Cefazolin (1000 mg) Powder for Solution for Injection. The required quantity is 3,000 units.
12. Ceftriaxone (2 g) Powder for Solution for Injection. The required quantity is 3,000 units.
13. Ciprofloxacin (500 mg) Film-Coated Tablets. The required quantity is 1,000 units.
14. Dalteparin (5000 i.u. / 0.2 ml) Solution for Injection. The required quantity is 10,000 units.

Reply

03 Aug 2021

United_States_of_America Flag

Various Finished Dosage Formulations needed in the United States [ENA10851]

A company that deals in pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The required quantity is 1 Billion units for each. The suppliers must support this enquiry with FDA (optional). The final market is the United States and Europe.
1) Valsartan (40 mg, 80 mg, 160 mg & 320 mg) Tablets
2) Glipizide (5 mg & 10 mg) Extended Release Tablets
3) Glipizide (5 mg & 10 mg) Tablets
4) Ibuprofen (400 mg, 600 mg & 800 mg) Tablets
5) Metoprolol Tartrate (25 mg, 50 mg & 100 mg) Tablets
6) Metoprolol Succinate (25 mg, 50 mg & 100 mg) Tablets
7) Atorvastatin (10 mg, 20 mg, 40 mg & 80 mg) Tablets
8) Atenolol (50 mg & 100 mg) Tablets
9) Valacyclovir (500 mg & 100 mg) Tablets

Reply

13 Jul 2021

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA10834]

Glavna direktsiya "Izpalnenie na nakazaniyata" is looking for supplies of Various Finished Dosage Formulations. The deadline is 04-Aug-2021.
1. Gentamicin (80 mg / 2 ml) Ampoules. The required quantity is 2,020 units.
2. Gliclazide (60 mg) Tablets. The required quantity is 7,210 units.
3. Glyceryl Trinitrate (5 mg) Tablets. The required quantity is 1,830 units.
4. Hydrochlorothiazide (25 mg) Tablets. The required quantity is 10,120 units.
5. Bisoprolol (10 mg) Tablets. The required quantity is 7,390 units.
6. Azithromycin (500 mg) Tablets. The required quantity is 2,625 units.
7. Atorvastatin (20 mg) Tablets. The required quantity is 6,880 units.
8. Atenolol (25 mg) Tablets. The required quantity is 2,700 units.
9. Amoxicillin (1000 mg) Film-coated Tablets. The required quantity is 27,180 units.
10. Amlodipine (10 mg) Tablets. The required quantity is 20,400 units.
11. Allopurinol (100 mg) Tablets. The required quantity is 4,740 units.
12. Ascorbic Acid (1000 mg) Effervescent Tablets. The required quantity is 1,500 units.
13. Carbamazepine (300 mg) Tablets. The required quantity is 9,300 units.
14. Carvedilol (6.25 mg) Tablets. The required quantity is 1,370 units.

Reply

10 Jul 2021

Looking for CTD Dossier of Atorvastatin (10 mg) + Ezetimibe (10 mg) & Atorvastatin (10 mg) Ezetimibe (20 mg) Tabl...

A pharmaceutical manufacturing & marketing company is Looking for CTD Dossier of Atorvastatin (10 mg) + Ezetimibe (10 mg) & Atorvastatin (10 mg) Ezetimibe (20 mg) Tablets for the Tunisian market.

Reply

16 Nov 2020

Tender// Various Finished Formulations needed in Poland [ENA09054]

Institute of Tuberculosis and Lung Diseases is looking for supply of medicinal products. The deadline is 23-Nov-2020.
1. Morphine Sulfate (10 mg / 1 ml) Solution for IV, SC and IM Injections
2. Fentanyl (2.75 mg, release rate 25 µg / h) Transdermal Patch
3. Oxycodone Hydrochloride (5 mg) Tablets
4. Alprazolam (0.25 mg) Tablets
5. Buprenorphine (20 mg patch, release rate 35 µg / h) Transdermal Patch
6. Clonazepam (0.5 mg) Tablets
7. Clozapine (100 mg) Tablets
8. Diazepam (10 mg / 2 ml) Ampoules
9. Phenobarbital (100 mg) Tablets
10. Lorazepam (1 mg) Tablets
11. Midazolam (7.5 mg) Tablets
12. Zolpidem (10 mg) Tablets
13. Haloperidol (5 mg) Injections
14. Allopurinol (100 mg) Tablets
15. Ambroxol (30 mg) Tablets
16. Atorvastatin (20 mg) Tablets
17. Cholecalciferol (1000 IU) Tablets
18. Dexamethasone (1 mg) Tablets
19. Digoxin (100 µg) Tablets
20. Paracetamol (500 mg) Tablets

Reply

14 Nov 2020

Various finished formulations needed in Malaysia [ENA04864]

A Malaysian company is looking for suppliers for various finished formulations mentioned below. The Supplier must support this enquiry with GMP from any PIC/S authorities, CTD dossier, and Stability Data Zone 4b.
1. Acetylsalicylic Acid 100mg Tablet
2. Fenofibrate 160mg, 145mg Tablet
3. Amox-Clav 500mg/125mg Tablet
4. Atorvastatin Calcium 40mg and 20mg Tablet
5. Bisacodyl 5mg Tablet
6. Bisoprolol Fumarate 10mg and 5mg Tablet
7. Celecoxib 400mg Capsule
8. Diclofenac 100mg Tablet
9. Domperidone10mg Tablet.

Reply

09 Aug 2019

saudiarabiapng-1555324364png-1605701218 Flag

Atorvastatin and various other formulations needed in UAE [ENA04382]

A leading global pharmaceutical company is looking for suppliers for the below products in GULF countries:
1. Atorvastatin
2. Rosuvastatin
3. Esomeprazole
4. Liraglutide
5. Metformin
6. Dapagliflozin
7. Fingolimod
8. Valsartan
9. Pregabalin
10. Levetiracetam
11. Enoxaparin Sodium
12. Amlodipine
13. Omeprazole
14. Glimepiride
15. Somatropin
16. Sitagliptin
17. Simvastatin
18. Gabapentin
19. Topiramate
20. Amlodipine + Perindopril
21. Rosuvastatin + Omega 3
22. Acetylsalicylic Acid + Clopidogrel
23. Sumatriptan
24. Cabergoline

Reply

12 Jun 2019

SaudiArabia Flag

Abiraterone tablets (500 mg) and Atorvastatin tablets (80 mg) formulations needed in Saudi Arabia [ENA04117]

A distribution company based in Saudi Arabia is looking for suppliers of Abiraterone tablets (500 mg) and Atorvastatin tablets (80 mg) formulations. Volume required 2,400 Tablets and 48,000 Tablets respectively.

Reply

08 May 2019

SouthAfrica Flag

Tender//Supply of various pharmaceuticals products to SADC Member states [ENA04014] [Part 1/3]

Part[1/3] The Government of the United Republic of Tanzania has issued submission of a bid for tender number IE-009/2018/2019/HQ/G/101 closing on 21/05/2019. Estimated quantities are for two years:
1. Acyclovir 200 mg Tablet (204,612 units)
2. Amodiaquine 150-200 mg Tablet
3. Amoxicillin 125 mg/5 ml Suspension (159,680 units)
4. Amoxicillin 500 mg Tablet/Capsule (679,240 units)
5. Artemether + Lumefantrine 20 + 120 mg 12 Tablet (588,306 units)
6. Bleomycin 15 IU Injection (20,244 units)
7. Chloramphenicol 250 mg Capsule (252,112 units)
8. Chloroquine 150 mg Tablet (15,400 units)
9. DPT Vaccine Injection (2,533,598 units)
10. Medroxyprogesterone Acetate 150 mg/ml Injection (513,524 units)
11. Nystatin 100,00 IU Pessary (337,356 units)
12. Simvastatin 20 mg Tablet (31,289 units)
13. Sodium Valproate 200 mg/5 ml Syrup (86,280 units)
14. Tamoxifen 20mg Tablet (99,137 units)
15. Amlodipine 5 mg Tablet (783,801 units)
16. Amoxicillin 250 mg Capsule (11,604,227 units)
17. Amoxicillin Dispersible Tablet 250 mg (12,067,546 units)
18. Artesunate 60 mg Injection (736,663 units)
19. Atenolol 50 mg Tablet (2,106,685 units)
20. Atorvastatin 20 mg Tablet (2,327,248 units).

Reply

25 Apr 2019

Milnacipran tablets, Amisulpride tablets and other formulations needed in China [ENA02733]

One of the largest ophthalmic distribution companies in China is looking for the following products :
1. Milnacipran tablets
2. Amisulpride 200 mg tablets
3. Sodium Hyaluronate 0.1% (preservative-free) Eye drops
4. Telmisartan/Amlodipine tablets
5. Amlodipine/Atorvastatin tablet
They looking for a 5 year supply contract for licensing into the Chinese Market. The product must already have EU Marketing Authorization OR US FDA ANDA."

Reply

23 Nov 2018

Enquiry// Various Pharmaceutical dossiers needed for registration in Guyana [ENA00213]

Pharma-X Consultancy Ltd (UK) is looking for Pharmaceutical Dossiers and sample products to facilitate registeration of below mentioned Products in Guyana:
1. Atorvastatin 20mg Tablets 28S
2. Gliclazide 80mg Tablets 28S
3. Ramipril 5mg Capsules 28S
4. Ramipril 10mg Capsules 28S
5. Atenolol 50mg Tablets 28S
6. Simvastatin 20mg Tablets 28S
7. Amlodipine 10mg Tablets 28S
8. Levothyroxine 100mcg Tablets 28S
9. Metformin 500mg Tablets 84S
10. Metformin 500mg Tablets 84S
11. Levothyroxine 50mcg Tablets 28S
12. Clopidogrel 75mg Tablets 28S/30S
13. Atorvastatin 40mg Tablets 28S
14. Codeine 30mg Tablets 28S
15. Amlodipine 5mg Tablets 28S
16. Co-Amoxiclav 625mg Tablets 21S
17. Atorvastatin 10mg Tablets 28S
18. Losartan 50mg Tablets 28S
19. Ciprofloxacin 500mg Tablets 20S
20. Spironolactone 25mg Tablets 28S
Interested suppliers can contact Ian Dhanraj via Email: pharmaxconsultanctltd@yahoo.co.uk or Tel: +44 (0) 7716202644.

Reply

14 Feb 2017

Enquiry//Atorvastatin Calcium Marketing Authorization needed for Germany [ENA00022]

Hamburg based AET, an active collaborator in all fields of pharmaceutical innovation, from generic drugs through biosimilars to novel product development is searching for an Atorvastatin Calcium marketing authorization to participate in the tender business in Germany.

AET, is a part of Alfred E. Tiefenbacher, the world's first exclusive active pharmaceuticals ingredient - API agency, which was founded in 1963.

Reply

17 Jun 2016